CLINICAL_TRIALS
trial_result
· 2013-03-25
Clinical Trial Update: Study of Capecitabine to Treat Recurrent High Grade Gliomas [Phase 2]
Summary
Phase 2 trial evaluating capecitabine for recurrent high-grade gliomas has completed; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Florida | Conditions: Malignant Glioma | Phase 2 | Status: COMPLETED | Results posted: 2013-03-25